Pinnacle Medicines is an emerging peptide drug discovery company based in Doylestown, Pennsylvania. Pinnacle has raised substantial Series A funding led by OrbiMed and Qiming Venture Partners, with the goal to discover first and best-in-class peptide therapeutics. The highly accomplished and experienced team at Pinnacle will utilize their deep know-how in peptide drug discovery, pioneering structure and AI-based drug design tools to realize the full potential of peptide modality as safe, effective and convenient therapeutics for unmet medical needs.
Company Details
- Employees
- 12
- Founded
- 2024
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Pinnacle Medicines Questions
Pinnacle Medicines's LinkedIn profile is https://www.linkedin.com/company/pinnaclemed
Pinnacle Medicines has
12 employees.
View email and phone details for 12
employees at Pinnacle Medicines.
Pinnacle Medicines's industry is
Biotechnology Research
Pinnacle Medicines's top competitors are
Terremoto Biosciences,
Revolution Medicines,
Optimeos Life Sciences,
Perpetual Medicines,
Ptc Therapeutics, Inc.,
Bristol Myers Squibb,
Legend Biotech,
Sk Life Science Labs,
Gsk,
Cybernax Bio.
Pinnacle Medicines's categories are Biotechnology Research
Pinnacle Medicines's founding year is 2024
